Resumo
Aluminum is a neurotoxicant and one of the most harmful metals in the environment; it is producing tissue inflammation and oxidative stress. Curcumin is an effective antioxidant and neuroprotective compound with medicinal potential. Curcumin's effect on AL toxicity was investigated in this study. Two groups of 70 mature adult albino rats were used, each of which was subdivided into five groups: Control, Vehicle, Curcumin, Aluminum, and Curcumin + Aluminum group. For two periods of 20 and 40 days, animal models were administered orally AlCl3 (20 mg kg-1 bw) and/or Curcumin (100 mg kg-1 bw). In the cerebral cortex, aluminum caused a significant rise (p < 0.05) in lipid peroxidation and DNA fragmentation, as well as a significant decrease (p < 0.05) in antioxidant enzymes such as catalase, superoxide dismutase, and glutathione peroxidase. In the brain hippocampus, aluminum caused a major reduction (p < 0.05) in neurotransmitters (dopamine and serotonin), while Acetylcholine esterase activity increased sharply (p < 0.05). Aluminum also triggered histological analyses in the hippocampus of the brain. Curcumin co-administration considerably reduced the increase in lipid peroxidation and DNA fragmentation, but also enhanced the depletion of antioxidant enzymes. Curcumin also reversed the decline in neurotransmitters, the increase in Acetylcholine esterase, and the distortion in the brain hippocampus.(AU)
Assuntos
Animais , Masculino , Ratos Endogâmicos/fisiologia , Curcumina/análise , Antioxidantes , Estresse Oxidativo , Fármacos NeuroprotetoresResumo
Purpose: To explore the role and mechanism of curcumin (Cur) in reducing oxidative stress damage in rats with nephrolithiasis induced by ethylene glycol (EG). Methods: Thirty male rats were divided into normal control, model, positive (10% potassium citrate), Cur-10 (10 mg/kg curcumin) and Cur-20 (20 mg/kg curcumin) groups. Results: The results of kidney tissue section stained by hematoxylin-eosin and von Kossa showed that curcumin treatment can inhibit the formation of kidney stones. The biochemical test results showed that the urea (Ur), creatinine (Cr), uric acid (UA), inorganic phosphorus and Ca2+ concentrations in urine decreased after being treated with curcumin. There were significant differences between different doses of curcumin (P < 0.05). Compared with the Cur-10 group, Cur-20 had a more significant inhibitory effect on malondialdehyde (MDA) (P < 0.05). In addition, reverse transcription polymerase chain reaction (PCR) detection and immunohistochemical results indicated that the osteopontin (OPN) in the kidney was significantly reduced after curcumin treatment. Conclusion: Curcumin could reduce the oxidative stress damage caused by EG-induced kidney stones.
Assuntos
Animais , Masculino , Ratos , Estresse Oxidativo/efeitos dos fármacos , Etilenoglicol/análise , Curcumina/administração & dosagem , Osteopontina/análise , Nefrolitíase/veterináriaResumo
Curcuma longa L., also known as turmeric, has been widely studied for its various therapeutic properties, including antineoplastic action. The ethanolic extract of the plant contains several phenolic compounds, especially curcumin. Osteosarcoma is a predominant bone tumor in dogs and humans, characterized by high metastatic potential and an unfavorable prognosis. The aim of this study was to investigate the effects of turmeric ethanol extract on canine osteosarcoma cells from established culture. The cells were cultured and treated with different curcumin concentrations (0, 10 µM, 20 µM, 50 µM, 100 µM, and 1000 µM) and exposure times (24h, 48h, and 72h). We first performed tetrazolium reduction technique (MTT) assay and calculated IC50. An immunocytochemistry assay was performed after extract treatment to verify the expression of mutated p53 and therefore study the proliferative potential of malignant cells; Bcl-2 and Ki-67 were used to assess apoptosis and the degree of malignancy, respectively. The extract enhanced the proliferation of canine osteosarcoma cells, reaching 3,819.74% at 50 µM of curcumin. The extract also significantly altered the expression of mutated p53 and Ki-67 proteins but not that of Bcl-2, suggesting that it did not induce this antiapoptotic pathway. Overall, these results are prerequisite to better understanding how natural compounds such as turmeric ethanolic extract affect cell proliferation and could be used to treat various diseases.
A Curcuma longa L., planta conhecida popularmente como açafrão, tem sido amplamente estudada por suas diversas propriedades terapêuticas, incluindo a ação antineoplásica. O extrato etanólico da planta contém diversos compostos fenólicos, com destaque para a curcumina. O osteossarcoma é um tumor ósseo predominante em cães e humanos, caracterizado por apresentar alto potencial metastático e prognóstico desfavorável. Procurou-se investigar os efeitos de diferentes concentrações de curcumina do extrato etanólico de açafrão sobre células de osteossarcoma canino de cultura estabelecida. As células foram cultivadas e submetidas ao tratamento com extrato com diferentes concentrações de curcumina (0, 10 µM, 20 µM, 50 µM, 100 µM e 1000 µM) e tempos de exposição (24h, 48h e 72h) pelo EEA. Inicialmente, foram realizados: técnica de redução do tetrazólio (MTT) e cálculo da IC50. Posteriormente, após o tratamento com o extrato, realizou-se o ensaio de imunocitoquímica para verificar a expressão de p53 mutada e estudar o potencial proliferativo das células malignas; Bcl-2, com intuito de averiguar o estímulo de via antiapoptótica; e o marcador Ki-67, que sinaliza aumento no grau de malignidade. O extrato promoveu proliferação de células de osteossarcoma canino, com incremento de até 3819,74% na concentração de 50µM de curcumina. O composto também alterou a expressão das proteínas p53 mutante e Ki-67 significativamente, mas não alterou a expressão de Bcl-2, mostrando que não induziu a via antiapoptótica mediada por esta. Estes resultados demonstram que o extrato etanólico do açafrão apresenta potencial proliferativo sobre células de osteossarcoma canino, sugerindo a necessidade de conscientização e conhecimento dos reais efeitos de determinados compostos naturais, considerados seguros ao serem utilizados como tratamento de diversas enfermidades.
Assuntos
Animais , Cães , Neoplasias Ósseas/veterinária , Osteossarcoma/veterinária , Curcumina , Curcuma , Proliferação de Células/efeitos dos fármacos , Técnicas In Vitro/veterinária , Doenças do Cão , Compostos FitoquímicosResumo
Purpose: To examine the effects of a negatively charged nanostructured curcumin microemulsion in experimental ulcerative colitis (UC) in rats. Methods: Four percent acetic acid was used to induce UC. The animals were treated for seven days and randomly assigned to four groups: normal control (NC), colitis/normal saline (COL/NS), colitis/curcumin (COL/CUR), and colitis/mesalazine (COL/MES). The nanostructured curcumin was formulated with a negative zeta potential (-16.70 ± 1.66 mV). Dosage of the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin 1-ß (IL-1ß), interleukin 6 (IL-6), and antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase), macro and microscopic evaluation of the colon tissue were analyzed. Results: The COL/CUR group had a higher level of antioxidant enzymes compared to the COL/MESgroup. The levels of TNF-α, IL-1ß and IL-6 were significantly lower in the colonic tissue of the COL/CUR group rats, when compared to the COL/NS and COL/MES groups (p < 0.001). The presence of ulcers in the colonic mucosa in rats of the COL/NSgroup was significantly higher than in the COL/MES group (p < 0.001). In the NC and COL/CUR groups, there were no ulcers in the colonic mucosa. Conclusions: The nanostructured microemulsion of curcumin, used orally, positively influenced the results of the treatment of UC in rats. The data also suggests that nanostructured curcumin with negative zeta potential is a promising phytopharmaceutical oral delivery system for UC therapy. Further research needs to be done to better understand the mechanisms of the negatively charged nanostructured curcumin microemulsion in UC therapy.
Assuntos
Animais , Ratos , Colite Ulcerativa , Curcumina , Inflamação , Fitoterapia , MucosaResumo
The objective of this study was to evaluate the effects of dietary supplementation with different doses of Curcuma longa hydrolate on the hematological, immunological and zootechnical parameters of Nile tilapia cultivated in a recirculation system (RAS). Nile tilapia (Oreochromis niloticus) were used, distributed in 16 polyethylene boxes, divided into four treatments: 0.0%; 2.5%; 7.5% and 10.0% of Curcuma longa hydrolate, in quadruplicate. After 45 days of treatment, four fish per experimental unit were anesthetized to remove blood aliquot for hematological and immunological analyzes and dissect the liver to evaluate the hepatosomatic index and final biometry. In the haematological analysis, the fish fed with 2.5% had a higher number of leukocytes, monocytes and lymphocytes than control, while the doses of 7.5% and 10.0% did not differ. Antimicrobial activity showed a significant decrease as the dose of C. longa hydrolate increased. The other hematological, immunological, hepatosomatic index and zootechnical data did not differ between treatments. Thus, supplementation of the hydrolate of Curcuma longa at a dosage of 2.5%, improved and maintained blood-immune homeostasis parameters in these animals, being suggested for further studies.(AU)
O objetivo deste estudo foi avaliar os efeitos da suplementação dietética com diferentes doses de hidrolato de Curcuma longa nos parâmetros hematológicos, imunológicos e zootécnicos da tilápia-do-nilo cultivada em sistema de recirculação. Utilizou-se tilápia- do-nilo (Oreochromis niloticus), distribuída em 16 caixas de polietileno, divididas em quatro tratamentos: 0,0%; 2,5%7,5% e 10,0% de hidrolato de Curcuma longa, em quadruplicata. Após 45 dias de tratamento, quatro peixes por unidade experimental foram anestesiados para remover uma alíquota sanguínea para análises hematológicas e imunológicas, e removeu-se o fígado para avaliar o índice hepatossomático e a biometria final. Na análise hematológica, os peixes alimentados com 2,5% apresentaram maior número de leucócitos, monócitos e linfócitos que no controle, enquanto as doses de 7,5% e 10,0% não diferiram. Por outro lado, a atividade antimicrobiana apresentou uma redução significativa à medida que a dose de hidrolato de C. longa aumentou. Os demais dados hematológicos, imunológicos, hepatossomáticos e zootécnicos não diferiram entre os tratamentos. Assim, a suplementação do hidrolato de Curcuma longa, na dose de 2,5%, melhorou os parâmetros hematoimunológicos e manteve a homeostase nesses animais, sendo sugerida para novos estudos.(AU)
Assuntos
Animais , Suplementos Nutricionais/análise , Curcumina/administração & dosagem , Ciclídeos/imunologia , Adjuvantes Imunológicos/uso terapêutico , Fitoterapia/veterináriaResumo
In addition to several local pathophysiological consequences, intestinal injury that is caused by ischemia and reperfusion can result in the development of lesions in remote organs. Curcumin has therapeutic potential because of its antiinflammatory and antioxidant effects. The present study evaluated the effects of curcumin on oxidative and inflammatory parameters in the liver and kidneys in rats that were subjected to intestinal ischemia and reperfusion. The rats were subjected to 45 min. of ischemia followed by 7 days of reperfusion and treated daily with 60 mg kg-1 curcumin. The liver and kidneys were collected, weighed, and biochemically analyzed. Intestinal ischemia and reperfusion increased levels of lipid hydroperoxide (LOOH), decreased levels of reduced glutathione (GSH), and increased the enzymatic activity of superoxide dismutase (SOD), glutathione S-transferase (GST), and myeloperoxidase (MPO) in the liver. Intestinal ischemia and reperfusion decreased kidney weight and increased GST activity in the kidneys. Curcumin prevented these changes in the liver and kidneys. Intestinal ischemia and reperfusion mainly affected the liver, promoting inflammation and oxidative stress. The kidneys underwent repair much earlier than the liver, in which they did not present alterations of MPO or main parameters of oxidative stress after 7 days of reperfusion. Treatment with curcumin had beneficial effects, ameliorating or even preventing injury that was caused by intestinal ischemia and reperfusion in the liver and kidneys in rats
Assuntos
Anti-Inflamatórios , Antioxidantes , Curcumina/análise , Isquemia , Isquemia/diagnósticoResumo
In addition to several local pathophysiological consequences, intestinal injury that is caused by ischemia and reperfusion can result in the development of lesions in remote organs. Curcumin has therapeutic potential because of its antiinflammatory and antioxidant effects. The present study evaluated the effects of curcumin on oxidative and inflammatory parameters in the liver and kidneys in rats that were subjected to intestinal ischemia and reperfusion. The rats were subjected to 45 min. of ischemia followed by 7 days of reperfusion and treated daily with 60 mg kg-1 curcumin. The liver and kidneys were collected, weighed, and biochemically analyzed. Intestinal ischemia and reperfusion increased levels of lipid hydroperoxide (LOOH), decreased levels of reduced glutathione (GSH), and increased the enzymatic activity of superoxide dismutase (SOD), glutathione S-transferase (GST), and myeloperoxidase (MPO) in the liver. Intestinal ischemia and reperfusion decreased kidney weight and increased GST activity in the kidneys. Curcumin prevented these changes in the liver and kidneys. Intestinal ischemia and reperfusion mainly affected the liver, promoting inflammation and oxidative stress. The kidneys underwent repair much earlier than the liver, in which they did not present alterations of MPO or main parameters of oxidative stress after 7 days of reperfusion. Treatment with curcumin had beneficial effects, ameliorating or even preventing injury that was caused by intestinal ischemia and reperfusion in the liver and kidneys in rats(AU)
Assuntos
Curcumina/análise , Isquemia/diagnóstico , Anti-Inflamatórios , Antioxidantes , IsquemiaResumo
Heat stress induces oxidative stress, and reduces body antioxidant metabolite levels, which can affect poultry production performance. Dietary antioxidants protect birds against the adverse effects of heat stress. The effects of increasing concentrations of dietary curcumin on the antioxidant parameters of layers maintained under high-temperature conditions for nine weeks were evaluated. Roman laying hens (n = 336, 22 weeks old, 1420 g BW) were divided into three treatment groups. The first group served as a thermoneutral control (kept at 25 ± 1 °C). The second group was exposed to high temperatures (32 ± 1 °C, 6 h/d), given a basal diet. The third group was further divided into five treatment groups (100, 150, 200, 250, 300 mg/kg Curcumin) fed a basal diet (treatments H1, H2, H3, H4, H5) under high temperatures conditions (32 ± 1 °C, 6 hours/day). As a result of this study, total superoxide dismutase activity was significantly higher in H2 and H3 groups, and total antioxidant capacity was higher in H2, H3, and H5 groups. Catalase and glutathione peroxidase activity was significantly higher in the H3 group. Malondialdehyde concentration was lowered in curcumin supplemented hens compared with control groups hens. Laying hens in all curcumin treatment groups had slightly higher activities of CAT, SOD, GSH-Px, and T-AOC in the liver, heart, and lungs, compared with heat stressed control group. It was concluded that dietary curcumin given to laying hens under heat stress may enhance their antioxidant status, and alleviate the detrimental effects of stressful environmental conditions.(AU)
Assuntos
Animais , Galinhas/fisiologia , Antioxidantes/análise , Curcumina/efeitos adversos , Curcumina/química , Temperatura Alta , Estresse OxidativoResumo
Heat stress induces oxidative stress, and reduces body antioxidant metabolite levels, which can affect poultry production performance. Dietary antioxidants protect birds against the adverse effects of heat stress. The effects of increasing concentrations of dietary curcumin on the antioxidant parameters of layers maintained under high-temperature conditions for nine weeks were evaluated. Roman laying hens (n = 336, 22 weeks old, 1420 g BW) were divided into three treatment groups. The first group served as a thermoneutral control (kept at 25 ± 1 °C). The second group was exposed to high temperatures (32 ± 1 °C, 6 h/d), given a basal diet. The third group was further divided into five treatment groups (100, 150, 200, 250, 300 mg/kg Curcumin) fed a basal diet (treatments H1, H2, H3, H4, H5) under high temperatures conditions (32 ± 1 °C, 6 hours/day). As a result of this study, total superoxide dismutase activity was significantly higher in H2 and H3 groups, and total antioxidant capacity was higher in H2, H3, and H5 groups. Catalase and glutathione peroxidase activity was significantly higher in the H3 group. Malondialdehyde concentration was lowered in curcumin supplemented hens compared with control groups hens. Laying hens in all curcumin treatment groups had slightly higher activities of CAT, SOD, GSH-Px, and T-AOC in the liver, heart, and lungs, compared with heat stressed control group. It was concluded that dietary curcumin given to laying hens under heat stress may enhance their antioxidant status, and alleviate the detrimental effects of stressful environmental conditions.
Assuntos
Animais , Antioxidantes/análise , Curcumina/efeitos adversos , Curcumina/química , Galinhas/fisiologia , Temperatura Alta , Estresse OxidativoResumo
A Cúrcuma (Curcuma longa) é uma planta originária do sudoeste asiático, que faz parte da família Zingiberaceae. É uma erva amarga, adstringente, com cheiro característico e forte cor amarela e que cujas raízes (rizomas) secas e maceradas têm sido utilizadas atualmente como corante e condimento para carnes e vegetais. O principal composto bioativo da cúrcuma é a curcumina, que se encontra em percentuais de dois a cinco por cento em suas raízes, sendo também é responsável pela sua coloração. Sabendo-se das suas propriedades bioativas e de várias que ainda estão sendo testadas, esse trabalho objetivou apresentar as principais propriedades e usos da cúrcuma. Historicamente a cúrcuma é empregada em diversos medicamentos utilizados pela medicina Ayurveda (sistema medicinal característico da Índia Antiga). Quimicamente é um pó insolúvel na água e no éter etílico, mas solúvel no etanol e acetona, é um diferoilmetano com a fórmula C21H20O6 e peso molecular 368,4. Muitos trabalhos estão sendo produzidos ultimamente buscando entender o funcionamento metabólico da curcumina e suas possíveis atividades biológicas. Entre as propriedades já estudadas destacam-se as capacidades anticoagulante, antifúngica, anti-inflamatória, antimalárica, antioxidante, antiviral, cicatrizante, esquistossomicida, hipolipemiante, leishmanicida, nematocida, tripanocida neuroprotetora, anti-amiloidogênica e imunomoduladora. A curcumina possui a vantagem de ser uma molécula de fácil acesso, uma vez que pode ser adquirida como condimento doméstico em todo o mundo e possui variadas aplicações, porém devido a sua baixa biodisponibilidade, baixa solubilidade em água e alta afinidade pelas proteínas plasmáticas faz-se necessário que novos estudos sejam realizados para que ela possa ser empregada efetivamente como um bioativo vegetal.(AU)
Turmeric (Curcuma longa) is a plant originated from Southeast Asia; it belongs to the Zingiberaceae family. It is a bitter, astringent herb, with a characteristic smell and strong yellow color. Its dried and macerated roots (rhizomes) have been used as coloring and condiment for meat and vegetables. Turmeric main bioactive compound is curcumin, which is found at concentrations of approximately two to five percent on its roots, being also responsible for its coloration. With the knowledge of its bioactive properties and of several other properties that are still being tested, this paper aimed at presenting the main properties and uses of turmeric. Turmeric has historically been used in various medicines by Ayurveda medicine (a medicinal system characteristic of ancient India). Chemically, it is a powder insoluble in either water or ethyl ether, despite being soluble in ethanol and acetone. It is a difoylmethane of formula C21H20O6 and molecular weight 368.4. Many works are being produced seeking to understand the metabolic functioning of curcumin and its possible biological activities. Among the properties already studied, it has proven anticoagulant, antifungal, anti-inflammatory, antimalarial, antioxidant, antiviral, scarring, schistosomicide, hypolipidemic, leishmanicidal, nematocidal, trypanocidal neuroprotective, anti-amyloidogenic and immunomodulatory capacities. Curcumin has the advantage of being an easily accessible molecule as it can be purchased as a domestic condiment worldwide and is widely applied in several cuisines. However, due to its low bioavailability, low water solubility and high affinity for plasma proteins, further studies should be carried out so that it can be effectively employed as a plant bioactive.(AU)
La cúrcuma (Curcuma longa) es una planta originaria del sudeste asiático, pertenece a la familia Zingiberaceae. Es una hierba amarga y astringente, con un olor característico y un fuerte color amarillo y cuyas raíces (rizomas) secas y maceradas se utilizan actualmente como colorante y condimento para carnes y vegetales. El principal compuesto bioactivo de la cúrcuma es la curcumina, que se encuentra cerca del dos al cinco por ciento de sus raíces y también es responsable por su coloración. Debido a sus propiedades bioactivas y de varias que aún se están probando, ese estudio tuvo como objetivo presentar las principales propiedades y usos de la cúrcuma. Históricamente, la cúrcuma es empleada en varias medicinas utilizadas por la medicina Ayurveda (sistema medicinal característico de la antigua India). Químicamente es un polvo insoluble en agua y éter etílico, pero soluble en etanol y acetona, es un diferoilmetano de fórmula C21H20O6 y peso molecular 368.4. Últimamente se están produciendo muchos trabajos que buscan comprender el funcionamiento metabólico de la curcumina y sus posibles actividades biológicas. Entre las propiedades ya estudiadas se encuentran las capacidades anticoagulante, antifúngica, antiinflamatoria, antipalúdica, antioxidante, antiviral, cicatrizante, esquistosomicida, hipolipidémica, leishmanicida, nematocida, tripanocida, neuroprotectora, antiamiloidogénica e inmunomoduladora. La curcumina tiene la ventaja de ser una molécula de fácil acceso, ya que se puede comprar como condimento doméstico en todo el mundo y tiene una variedad de aplicaciones, pero debido a su baja biodisponibilidad, baja solubilidad en agua y alta afinidad por las proteínas plasmáticas se hace necesario que nuevos estudios sean llevados a cabo para que ella pueda ser empleada efectivamente como planta bioactiva.(AU)
Assuntos
Curcumina/análise , Curcuma/classificação , Curcuma/química , Compostos Fitoquímicos/análiseResumo
A Cúrcuma (Curcuma longa) é uma planta originária do sudoeste asiático, que faz parte da família Zingiberaceae. É uma erva amarga, adstringente, com cheiro característico e forte cor amarela e que cujas raízes (rizomas) secas e maceradas têm sido utilizadas atualmente como corante e condimento para carnes e vegetais. O principal composto bioativo da cúrcuma é a curcumina, que se encontra em percentuais de dois a cinco por cento em suas raízes, sendo também é responsável pela sua coloração. Sabendo-se das suas propriedades bioativas e de várias que ainda estão sendo testadas, esse trabalho objetivou apresentar as principais propriedades e usos da cúrcuma. Historicamente a cúrcuma é empregada em diversos medicamentos utilizados pela medicina Ayurveda (sistema medicinal característico da Índia Antiga). Quimicamente é um pó insolúvel na água e no éter etílico, mas solúvel no etanol e acetona, é um diferoilmetano com a fórmula C21H20O6 e peso molecular 368,4. Muitos trabalhos estão sendo produzidos ultimamente buscando entender o funcionamento metabólico da curcumina e suas possíveis atividades biológicas. Entre as propriedades já estudadas destacam-se as capacidades anticoagulante, antifúngica, anti-inflamatória, antimalárica, antioxidante, antiviral, cicatrizante, esquistossomicida, hipolipemiante, leishmanicida, nematocida, tripanocida neuroprotetora, anti-amiloidogênica e imunomoduladora. A curcumina possui a vantagem de ser uma molécula de fácil acesso, uma vez que pode ser adquirida como condimento doméstico em todo o mundo e possui variadas aplicações, porém devido a sua baixa biodisponibilidade, baixa solubilidade em água e alta afinidade pelas proteínas plasmáticas faz-se necessário que novos estudos sejam realizados para que ela possa ser empregada efetivamente como um bioativo vegetal.(AU)
Turmeric (Curcuma longa) is a plant originated from Southeast Asia; it belongs to the Zingiberaceae family. It is a bitter, astringent herb, with a characteristic smell and strong yellow color. Its dried and macerated roots (rhizomes) have been used as coloring and condiment for meat and vegetables. Turmeric main bioactive compound is curcumin, which is found at concentrations of approximately two to five percent on its roots, being also responsible for its coloration. With the knowledge of its bioactive properties and of several other properties that are still being tested, this paper aimed at presenting the main properties and uses of turmeric. Turmeric has historically been used in various medicines by Ayurveda medicine (a medicinal system characteristic of ancient India). Chemically, it is a powder insoluble in either water or ethyl ether, despite being soluble in ethanol and acetone. It is a difoylmethane of formula C21H20O6 and molecular weight 368.4. Many works are being produced seeking to understand the metabolic functioning of curcumin and its possible biological activities. Among the properties already studied, it has proven anticoagulant, antifungal, anti-inflammatory, antimalarial, antioxidant, antiviral, scarring, schistosomicide, hypolipidemic, leishmanicidal, nematocidal, trypanocidal neuroprotective, anti-amyloidogenic and immunomodulatory capacities. Curcumin has the advantage of being an easily accessible molecule as it can be purchased as a domestic condiment worldwide and is widely applied in several cuisines. However, due to its low bioavailability, low water solubility and high affinity for plasma proteins, further studies should be carried out so that it can be effectively employed as a plant bioactive.(AU)
La cúrcuma (Curcuma longa) es una planta originaria del sudeste asiático, pertenece a la familia Zingiberaceae. Es una hierba amarga y astringente, con un olor característico y un fuerte color amarillo y cuyas raíces (rizomas) secas y maceradas se utilizan actualmente como colorante y condimento para carnes y vegetales. El principal compuesto bioactivo de la cúrcuma es la curcumina, que se encuentra cerca del dos al cinco por ciento de sus raíces y también es responsable por su coloración. Debido a sus propiedades bioactivas y de varias que aún se están probando, ese estudio tuvo como objetivo presentar las principales propiedades y usos de la cúrcuma. Históricamente, la cúrcuma es empleada en varias medicinas utilizadas por la medicina Ayurveda (sistema medicinal característico de la antigua India). Químicamente es un polvo insoluble en agua y éter etílico, pero soluble en etanol y acetona, es un diferoilmetano de fórmula C21H20O6 y peso molecular 368.4. Últimamente se están produciendo muchos trabajos que buscan comprender el funcionamiento metabólico de la curcumina y sus posibles actividades biológicas. Entre las propiedades ya estudiadas se encuentran las capacidades anticoagulante, antifúngica, antiinflamatoria, antipalúdica, antioxidante, antiviral, cicatrizante, esquistosomicida, hipolipidémica, leishmanicida, nematocida, tripanocida, neuroprotectora, antiamiloidogénica e inmunomoduladora. La curcumina tiene la ventaja de ser una molécula de fácil acceso, ya que se puede comprar como condimento doméstico en todo el mundo y tiene una variedad de aplicaciones, pero debido a su baja biodisponibilidad, baja solubilidad en agua y alta afinidad por las proteínas plasmáticas se hace necesario que nuevos estudios sean llevados a cabo para que ella pueda ser empleada efectivamente como planta bioactiva.(AU)
Assuntos
Curcumina/análise , Curcuma/classificação , Curcuma/química , Compostos Fitoquímicos/análiseResumo
To examine the therapeutic effect of curcumin and/or vitamin B6 in treatment of cholestasis, a model of cholestasis was induced in mice using lithocholic acid (LCA). Alterations in biochemical parameters and liver histopathological and histochemical changes were examined in cholestatic mice and after treatments with curcumin, vitamin B6 and combination of both. Moreover, hepatic expressions of bilirubin-metabolizing enzymes, their regulatory nuclear receptors, and bile acid lipid transporters were examined using RT-PCR. Cholestatic mice showed an increase in the blood levels of AST, ALT, ALP, direct and total bilirubin and a decrease in cholesterol levels that were ameliorated by treatments. Liver histopathology showed multiple necrotic foci of different sizes spread all over the liver with congestion of hepatic blood vessels in LCA group. These foci were regenerated in hepatic tissues after administration of curcumin and vitamin B6. Immunohistochemical examination of liver showed an increase in glutathione and NF-kB expressions in treated mice. Cholestatic mice showed down-regulation of mRNA expression of hepatic bile acid and bilirubin-metabolizing/detoxifying enzymes (Cyp2b10, Ugt1a1, Sult2a1), their regulatory nuclear receptors (CAR, PXR, farnesoid X receptor), and bile acid/organic anion and lipid transporters (Oatp2, Bsep, Mrp2, Abcg8, Asbt). These changes were ameliorated and restored by treatment with curcumin, vitamin B6 and both. Only of examined genes, NTCP was up-regulated in cholestatic mice. In conclusion, treatment with curcumin mainly, vitamin B6 or the combination of them has the potential to ameliorate changes observed in induced cholestasis.
Assuntos
Animais , Camundongos , Colestase/veterinária , Curcumina/análise , Curcumina/uso terapêutico , Fígado/lesões , /análise , /uso terapêutico , Ácido LitocólicoResumo
To examine the therapeutic effect of curcumin and/or vitamin B6 in treatment of cholestasis, a model of cholestasis was induced in mice using lithocholic acid (LCA). Alterations in biochemical parameters and liver histopathological and histochemical changes were examined in cholestatic mice and after treatments with curcumin, vitamin B6 and combination of both. Moreover, hepatic expressions of bilirubin-metabolizing enzymes, their regulatory nuclear receptors, and bile acid lipid transporters were examined using RT-PCR. Cholestatic mice showed an increase in the blood levels of AST, ALT, ALP, direct and total bilirubin and a decrease in cholesterol levels that were ameliorated by treatments. Liver histopathology showed multiple necrotic foci of different sizes spread all over the liver with congestion of hepatic blood vessels in LCA group. These foci were regenerated in hepatic tissues after administration of curcumin and vitamin B6. Immunohistochemical examination of liver showed an increase in glutathione and NF-kB expressions in treated mice. Cholestatic mice showed down-regulation of mRNA expression of hepatic bile acid and bilirubin-metabolizing/detoxifying enzymes (Cyp2b10, Ugt1a1, Sult2a1), their regulatory nuclear receptors (CAR, PXR, farnesoid X receptor), and bile acid/organic anion and lipid transporters (Oatp2, Bsep, Mrp2, Abcg8, Asbt). These changes were ameliorated and restored by treatment with curcumin, vitamin B6 and both. Only of examined genes, NTCP was up-regulated in cholestatic mice. In conclusion, treatment with curcumin mainly, vitamin B6 or the combination of them has the potential to ameliorate changes observed in induced cholestasis.(AU)
Assuntos
Animais , Camundongos , Curcumina/análise , Curcumina/uso terapêutico , Vitamina B 6/análise , Vitamina B 6/uso terapêutico , Fígado/lesões , Colestase/veterinária , Ácido LitocólicoResumo
Purpose: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). Methods: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. Results: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. Conclusions: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.(AU)
Assuntos
Animais , Masculino , Adulto , Ratos , Curcumina/análogos & derivados , Curcumina/farmacologia , Curcumina/uso terapêutico , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Proteínas Quinases , Canais de Potencial de Receptor Transitório , Complicações do Diabetes/induzido quimicamente , Complicações do Diabetes/tratamento farmacológicoResumo
Purpose: To investigate thymoquinone, curcumin and a combination of these two drugs were effective or not at the growth of liver.Methods: Forty female Wistar-Albino rats distributed into five groups of eight rats each, control, thymoquinone, curcumin, and thymoquinone/curcumin groups. Pathological specimens were studied using the Ki-67 Proliferation Index(PI); and arginase(Arg), tissue plasminogen activator(tPA), ceruloplasmin(Cer) and nitric oxide(NO) were studied in biochemical analysis.Results: Our results showed that Ki-67 proliferation index was low in Groups 1. The proliferation coefficient was significantly higher in the Group 2 and Group 4 than in the Group 1 and Group 3.(P < 0.001 between Groups 1 and 2, 1 and 4, and 3 and 4). There was no difference between Groups 2 and 4 (P = 1). The results of the biochemical Arg, tPA and Cer test showed statistically between the Group 1 and Group 2. NO showed significant differences Group 1 and 3.Conclusions: Thymoquinone and curcumin both have known positive effects on the organism. Histological and biochemical tests showed that thymoquinone is more effective than curcumin.(AU)
Assuntos
Animais , Feminino , Ratos , Nigella sativa , Curcumina/uso terapêutico , Fitoterapia , Hepatectomia , Regeneração Hepática , Extratos Vegetais/uso terapêutico , Modelos Animais , Ratos WistarResumo
Purpose: To evaluate the impact of systemic cyclophosphamide treatment on the rat uterus and investigate the potential therapeutic effects of natural antioxidant preparations curcumin and capsaicin against cyclophosphamide side effects. Methods: A 40 healthy adult female Wistar albino rats were used in this study. Rats were randomly divided into four groups to determine the effects of curcumin and capsaicin against Cyclophosphamide side effects on the uterus (n=10 in each group); Group 1 was the control group (sham-operated), Group 2 was the cyclophosphamide group, Group 3 was the cyclophosphamide + curcumin (100mg/kg) group, and Group 4 was the cyclophosphamide + capsaicin (0.5 mg/kg) group. Results: Increased tissue oxidative stress and histological damage in the rat uterus were demonstrated due to the treatment of systemic cyclophosphamide chemotherapy alone. The level of tissue oxidant and antioxidant markers and histopathological changes were improved by the treatment of curcumin and capsaicin. Conclusion: Cytotoxic effects of natural alkylating chemotherapeutic agents like cyclophosphamide on the uterus can be prevented by curcumin and capsaicin.(AU)
Assuntos
Animais , Feminino , Adulto , Ratos , Ciclofosfamida/efeitos adversos , Neoplasias Uterinas/terapia , Curcumina/uso terapêutico , Capsaicina/uso terapêutico , Ratos WistarResumo
Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post-treatment.[...]
Assuntos
Feminino , Animais , Aditivos Alimentares/uso terapêutico , Curcumina/uso terapêutico , Mastite/terapia , Mastite/veterinária , OvinosResumo
Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post-treatment.[...](AU)
Assuntos
Animais , Feminino , Ovinos , Mastite/terapia , Mastite/veterinária , Aditivos Alimentares/uso terapêutico , Curcumina/uso terapêuticoResumo
Purpose: To measure the tissue sulfomucin and sialomucin content of the colon mucosa without fecal flow, subjected to intervention with curcumin, and the influence of the concentration used and the intervention time. Methods: Thirty-six rats were subjected to proximal right colostomy and distal mucous fistula. They were divided into two groups according to whether sacrifice was performed two or four weeks after the intervention. Each group was divided into three subgroups according to the enema applied daily: saline alone; curcumin at 50 mg/kg/day or curcumin at 200 mg/kg/day. Acid mucins were diagnosed using the Alcian blue technique. The mucin content was quantified by means of computer-assisted image analysis. The significance level of 5% was used throughout (p 0.05). Results: There were dose-related increases in the quantities of sulfomucins in the animals subjected to interventions with curcumin, both after two weeks (p 0.00001) and after four weeks (p 0.00001). There were increases in sialomucin quantity that were concentration-related (p 0.00001) and time-related (p 0.00001). Conclusion: Curcumin enemas increase the quantity of acid mucins in the intestinal flow in the excluded colon, with dose and time dependency.(AU)
Assuntos
Animais , Masculino , Ratos , Curcumina/administração & dosagem , Curcumina/uso terapêutico , Curcuma , Mucinas/análise , Sialomucinas/análise , Colo/fisiopatologia , Colo/cirurgia , Colite/cirurgia , Colite/terapia , Mucosa , Colostomia/métodos , EnemaResumo
A Osteoartrite (OA) é uma denominação clínica para uma combinação de condições patológicas que envolvem a degeneração progressiva da cartilagem articular e remodelação de osso subcondral. A curcumina, um potente agente anti-inflamatório, têm sido extensivamente estudada, no entanto não oferece boa biodisponibilidade sistêmica. Nanopartículas de ouro (AuNPs) apresentam aplicações potenciais na administração de substâncias terapêuticas aumentando a eficiência do transporte de fármacos. O objetivo deste estudo foi realizar a síntese e caracterização de um sistema conjugando as AuNPs à curcumina e avaliar seu potencial terapêutico em um modelo experimental de OA em camundongos por desestabilização do menisco medial (DMM). As AuNPs foram conjugadas com curcumina e os sistemas foram caracterizados por espectroscopia no UV-VIS, espalhamento de luz dinâmico (DLS) e determinação do potencial zeta. Formou-se 4 grupos de oito animais cada, denominados A, B, C, D que receberam injeção intra-articular de AuNPs, curcumina, AuNP-curcumina e solução fisiológica, respectivamente. Após 7 semanas, a cartilagem da articulação-femoro- tibio-patelar (AFTP) foi avaliada em uma variação de escore de 0 a 24. A conjugação de AuNP-curcumina mostrou boa estabilidade e aplicação terapêutica, mas não diferiu significativamente (P>0,05) dos grupos A e B, no entanto, mostrou menor valor de escore e significância (P<0,001) em relação ao grupo controle. Os resultados deste trabalho mostram a importância do desenvolvimento de novos nanofármacos. Neste caso a conjugação de AuNPs com a curcumina permitiu a obtenção de um nanofármaco com sugestivo potencial para aplicação no tratamento da OA.
Osteoarthritis (OA) is the clinical term for a combination of pathological conditions that involve the progressive degeneration of articular cartilage and subchondral bone remodelling. Curcumin, a potent anti-inflammatory agent, has been extensively studied; however, it does not provide good systemic bioavailability. Gold nanoparticles (AuNPs) have potential applications in the administration of therapeutic substances in order to increase the transport efficiency of drugs. The objectives of this study were to explore the synthesis and characterization of a system combining AuNPs with curcumin and evaluate its therapeutic potential in an experimental model of OA in mice by the destabilization of the medial meniscus (DMM). The AuNPs were conjugated with curcumin and the systems were characterized by UV-VIS spectroscopy, dynamic light scattering (DLS), and zeta potential. Four groups of eight animals each were formed and labelled A, B, C, and D, which received intra-articular injections of AuNPs, curcumin, AuNP-curcumin, and physiologic solution, respectively. After seven weeks, the cartilage of the stifle joint (SJ) was rated on a scale ranging from 0 to 24. Combination of AuNP-curcumin demonstrated good stability and therapeutic applications, but it did not differ significantly (P>0.05) from groups A and B. However, the control group had a significantly lower score (P<0.001). Results of this study demonstrated the importance of developing new nanodrugs. In this case, the combination of AuNPs and curcumin yielded the nanodrug effects suggestive of a potential for application in the treatment of OA.